Filtering by:
Cancer UpdatesFDA Approves Libtayo (Cemiplimab) for a Type of Skin Cancer
The US Food and Drug Administration (FDA) has approved Libtayo (cemiplimab) to treat people with advanced squamous cell carcinoma of the skin.
Report: Cancer Risk Varies Widely Among Hispanic Americans
A new report from the American Cancer Society highlights the wide variation in cancer risk within the US Hispanic/Latino population.
Nobel Prize Awarded to Cancer Immunotherapy Researchers
The 2018 Nobel Prize in Physiology or Medicine has been awarded jointly to two cancer immunotherapy researchers, James P. Allison, PhD, of The University of Texas MD Anderson Cancer Center, and Dr. Tasuku Honjo of Kyoto University in Japan.
FDA Approves Lumoxiti (Moxetumomab Pasudotox) for Hairy Cell Leukemia
The US Food and Drug Administration (FDA) has approved Lumoxiti (moxetumomab pasudotox-tdfk) for adults with hairy cell leukemia (HCL) that did not get better with at least 2 different previous treatments or got better but then came back.
More Teens Getting HPV Vaccinations
The US Centers for Disease Control and Prevention (CDC) reports that almost half (49%) of teenagers have been fully vaccinated for human papillomavirus (HPV), an increase of 5 percentage points from 2016.
FDA Approves Opdivo (Nivolumab) for Small Cell Lung Cancer
The US Food and Drug Administration had approved the immunotherapy drug Opdivo (nivolumab) to treat people with small cell lung cancer (SCLC).
Cancer Patients Want More Information From Doctors About Cost
A study led by researchers from University of Michigan has found that many cancer patients would like more help from their health care providers in addressing costs of treatment.
FDA Approves Poteligeo (Mogamulizumab) for Lymphoma of the Skin
The US Food and Drug Administration (FDA) has approved Poteligeo (mogamulizumab) to treat people with some types of skin lymphoma.